Form 4: Phreesia SVP, David Linetsky, Acquires Shares Through Vesting of Performance-Based Restricted Stock Units
SEC Form 4 Filing
David Linetsky, SVP of Life Sciences at Phreesia, acquired 19,564 shares of common stock due to the vesting of performance-based restricted stock units.
Summary
- David Linetsky, a Senior Vice President at Phreesia, acquired 19,564 shares of common stock on January 23, 2025.
- These shares were obtained through the vesting of performance-based restricted stock units (PSUs).
- The performance period for these PSUs concluded on January 14, 2025.
- The number of shares earned was determined by the Compensation Committee on January 23, 2025, based on the company's achievement of pre-established performance criteria.
- Following this transaction, Mr. Linetsky directly owns 242,956 shares of common stock and indirectly owns 8,851 shares through his spouse.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation. The vesting of shares based on performance is a positive indicator of company performance, but it is not an unusual event.
Positives
- The vesting of performance-based restricted stock units indicates that the company met pre-established performance criteria.
- The acquisition of shares by a senior executive can be seen as a positive sign of confidence in the company's future.
Industry Context
This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders acquire or dispose of company stock. It reflects standard executive compensation practices.
Comparison to Industry Standards
- The vesting of performance-based restricted stock units is a common practice in the technology and healthcare industries, aligning executive compensation with company performance.
- Many companies, such as Veeva Systems and athenahealth, use similar equity-based compensation plans for their executives.
- The specific performance criteria and vesting schedules vary by company, but the general principle of rewarding performance with equity is widespread.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it indicates that the company met performance targets.
- The transaction has a positive impact on the executive as it is part of their compensation package.
Key Dates
| Date | Description |
|---|---|
| 01/14/2025 | End of the performance period for the restricted stock units. |
| 01/23/2025 | Date of the transaction and certification of shares earned by the Compensation Committee. |
| 01/24/2025 | Date of the signature of the report. |
Keywords
Phreesia, stock, vesting, performance-based restricted stock units, PSUs, insider trading, executive compensation, equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.